Monitoring and controlling drug precursors
01020304050607
With the European Parliament, which is preparing its first-reading position.
Last active 20 May 2026
Track this billGet an email when the proposal moves: phase change, new document, or terminal outcome.
What this bill does
In plain terms: what it changes and who it affects.
This proposal tightens EU controls on chemicals used to make illegal drugs while simplifying lawful trade through one digital system.
Who it affects
It affects chemical manufacturers, distributors, importers, exporters, online marketplaces, research organisations, pharmacies, veterinary dispensaries, and industries using precursor chemicals, especially SMEs.
Core of the proposal
- Merges internal-market and external-trade precursor rules into one directly applicable regulation.
- Creates a new banned category for designer precursors, with limited research and innovation exceptions.
- Replaces several paper or authorisation processes with a central electronic system and customs interconnection.
- Strengthens reporting, seizure, customs-control, training, and online marketplace obligations for suspicious precursor activity.
Key provisions
- Takes effect
- It enters into force 20 days after Official Journal publication and generally applies three years after entry into force.
- Transitional law
- Existing licences and registrations remain valid until expiry or four years after entry into force, whichever comes first.
Articles changed · 2 across 2 laws
- Regulation (EC) No 273/2004 (32004R0273)
- entire act: repeals the entire regulation
- Regulation (EC) No 111/2005 (32005R0111)
- entire act: repeals the entire regulation
Latest update
12 Jun 2026The most recent development in this bill's progress.
1st reading – European Parliament → 1st reading – European Parliament
1st reading – European Parliament → 1st reading – European Parliament
Documents
1 recentSourcesOEILEUR-LexEU Law Tracker